TELA Bio (TELA) raises ~$34.2M in public offering of 4.6M shares at $8.00

TELA Bio, Inc.

Underwriting agreement with Lake Street Capital Markets for 4M shares at $8.00/share; option for 600K additional shares exercised in full.
Net proceeds expected to be approximately $34.2 million after underwriting discounts and offering expenses.
Proceeds intended for working capital, general corporate purposes, including R&D, manufacturing, and potential acquisitions.
Offering expected to close on August 18, 2022, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.